Lee Ainslie’s Medpace MEDP Stock Holding History

Lee Ainslie’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,228	Closed	-$3.12M	–	284
2025 Q1	$3.12M	Buy	+10,228	New	+$3.44M	0.06%	96
2023 Q2	–	Sell	-7,508	Closed	-$1.41M	–	499
2023 Q1	$1.41M	Buy	+7,508	New	+$1.55M	0.04%	107

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Lee Ainslie's MEDP Position: Q2 2025 in Review

Lee Ainslie sold out of Medpace (MEDP) in Q2 2025, closing a stake of 10,228 shares — an estimated $3.12M sold.

Lee Ainslie first reported a position in MEDP in Q1 2023 and held it in 2 quarters. The position peaked at $3.12M in Q1 2025. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

Lee Ainslie reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
Lee Ainslie sold 10,228 Medpace shares in Q2 2025, an estimated $3.12M.
Lee Ainslie first reported a position in Medpace in Q1 2023 and held it in 2 quarters.
Lee Ainslie's Medpace position peaked at $3.12M in Q1 2025.
602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Maverick Capital's 13F filing for Q2 2025, filed 14 Aug 2025.